InterVenn
Developer of a biomarker and target discovery platform designed to help in the detection and triaging of ovarian and oth
Decision/Risk Analysis
📍 South San Francisco, CA
Founded 2017
Current Valuation
$601M
as of 2021-Q3
PRIVATE
Developer of a biomarker and target discovery platform designed to help in the detection and triaging of ovarian and other cancers.
Company Profile
HQ
South San Francisco, CA
Last Round
Series C — $201M (Aug 2021)
Fundraising Status
Series C · $201M · 4y 10mo ago
privateTotal raised $244M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $201M | Aug 2021 | — | $601M |
MedicalBiotechnologyLife ScienceArtificial IntelligenceMachine Learning
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q3. Refreshed quarterly.